Thermo Reversible Hydrogel Based Delivery of Mitomycin C (UGN-101) for Treatment of Upper Tract Urothelial Carcinoma (UTUC)-Reference-Cited by-同舟云学术

Thermo Reversible Hydrogel Based Delivery of Mitomycin C (UGN-101) for Treatment of Upper Tract Urothelial Carcinoma (UTUC)

Published:2019-01-31 Issue:1 Volume:5 Page:21-29
ISSN:2352-3727
Container-title:Bladder Cancer
language:
Short-container-title:BLC

Author:

Kleinmann Nir¹,Wirth Gregory²,Lin Jeffrey S.³,Matin Surena F.⁴,Nativ Ofer⁵,Mayer Gil⁵,Witjes J. Alfred⁶,Shvero Asaf¹,Chamie Karim⁷,Pantuck Allan J.⁷,Smith Angela⁸,Schoenberg Mark⁹¹⁰,Malchi Nadav¹⁰,Hakim Gil¹⁰,Agmon-Gerstein Yael¹⁰,Jeshurun-Gutshtat Michal¹⁰,Klein Ifat¹⁰,Kopelen Helen³,Lerner Seth P.³

Affiliation:

1. Chaim Sheba Medical Center, Tel-Hashomer, Israel

2. Geneva University Hospital, Switzerland

3. Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA

4. MD Anderson Cancer Center, Houston, TX, USA

5. Benai-Zion Medical Center, Haifa, Israel

6. Radboud university hospital Nijmegen, Netherlands

7. University of California Los Angeles, CA, USA

8. University of North Carolina, USA

9. The Montefiore Medical Center and The Albert Einstein College of Medicine, Bronx, NY, USA

10. UroGen, Pharma Ltd., Ra’anana, Israel

Publisher